Status:

UNKNOWN

TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)

Lead Sponsor:

Tongji University

Collaborating Sponsors:

Interventional Radiology Research Group, Shanghai Radiology Society

Conditions:

Hepatitis B Virus

Hepatocellular Carcinoma

Eligibility:

All Genders

20-75 years

Phase:

PHASE2

Brief Summary

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in China, and approximately 90% of the patients with HCC are also infected with hepatitis B virus (HBV). For patients with unre...

Detailed Description

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies in China, and approximately 90% of the patients with HCC are also infected with hepatitis B virus (HBV). Until now, no standard...

Eligibility Criteria

Inclusion

  • age:20-75 years old
  • with a clinical diagnosis of primary liver cancer, with HBsAg positive,without any therapy for tumor
  • single lesion with a diameter \>6.5 cm,or multiple lesions locating within half liver or adjacent three lobe
  • estimated liver remnant volume ≤40%
  • with a liver function of Child-Pugh class A,and ALT≤80IU/l.

Exclusion

  • reject to attend
  • portal vein trunk has been compressed by tumor
  • diffuse type cancer or with extensive cancer thrombus in main branches of PV,HV,IVC or bile duct
  • with extrahepatic metastasis
  • with obvious portal hypertension (with moderate to severe varix in esophagus and/or gastric fundus, enlarged spleen,WBC\<4×109/L, PLT\<80×109/L)
  • with diabetes
  • allergy to iodine

Key Trial Info

Start Date :

August 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 1 2015

Estimated Enrollment :

216 Patients enrolled

Trial Details

Trial ID

NCT00960518

Start Date

August 1 2009

End Date

August 1 2015

Last Update

August 17 2009

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

The Fourth Affiliated Hospital of Haerbin Medical University

Ha'er'bin, Heilongjiang, China, 150001

2

Shanghai 10th Hospital of Tongji University

Shanghai, Shanghai Municipality, China, 200025